商业化战略的决定因素:英国和德国生物技术产业的特殊性

The Determinants of Commercialization Strategy: Idiosyncrasies in British and German Biotechnology

ENTREPRENEURSHIP THEORY AND PRACTICE · 2010
被引 31
人大 AFT50ABS 4

中文导读

研究了市场因素对英国(自由市场经济)和德国(协调经济)生物技术企业商业化战略决策的影响,发现两国存在不同模式。

Abstract

The intention of this paper is to investigate whether market–related factors have a stronger influence on the strategic decision making of ventures in “liberal market economies” than on that of their counterparts in “coordinated economies.” Thereby, I focus on a particularly important strategic decision that firms face—the commercialization choice. Using a unique survey data set on the commercialization of British and German biotechnology firms, I analyze the determinants of commercialization strategy, paying particular attention to national idiosyncrasies. Together, the findings indicate that the commercialization strategy follows distinct patterns in the British “liberal market economy” and the German “coordinated economy.”

生物技术商业化战略制度经济学比较经济体制